Skip to main content
. 2017 Dec 4;23(3):482–489. doi: 10.1007/s10147-017-1220-0

Table 2.

Treatment-related adverse events (AEs)

n = 136 (%)
Any AEs 103 (76)
Grade ≥3 AEs 60 (44)
Nonhematological grade ≥3 AEs 16 (12)
Most common AEs, any grade
 Diarrhea 16 (12)
 Nausea 26 (19)
 Vomiting 7 (5)
 Anorexia 21 (15)
 Mucositis 9 (7)
 Fatigue 50 (37)
Grade ≥3 laboratory abnormalities
 Neutropenia 44 (32)
 Leukopenia 8 (6)
 Anemia 7 (5)
 Thrombocytopenia 1 (1)
 Increased total bilirubin 2 (2)
Serious AEs 5 (4)
 Resulting from febrile neutropenia 3 (2)
 Resulting from gastrointestinal toxicities 2 (2)

AE adverse event